Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis

ConclusionOur study reports for the first time a high incidence (48.1%) of intramyocardial inflammation in a series of patients with EMB‐proven cardiac amyloidosis and could show that in patients with AL amyloidosis, intramyocardial inflammation correlated significantly with increased mortality. Our data have a direct clinical impact because one can hypothesize that additional immunomodulating/anti‐inflammatory treatment regimens in patients with biopsy‐proven inflammation of heart muscle tissue could be beneficial for patients suffering from cardiac AL amyloidosis.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Tags: Research Article Source Type: research